The next generation of Whole Blood CRP LIT Assay was developed for quantitative determination CRP for point of care testing (POCT-CRP).
 JPG.jpg)
Learn more about C-reactive protein
Immediate Testing for CRP Concentration; Fastest in the industry
- Good Biotech Corp. Whole blood CRP LIT Assay (REF: KT-0301-W) is intended to be used for the quantitative determination of C-reactive protein in whole blood, serum and plasma by latex particle enhanced immunoturbidimetry (LIT). The measurement of C-reactive protein aids in evaluation and detection of the amount of infection, tissue injury, inflammatory disorders and associated diseases.
- The one and only one IgY-based Human CRP Immunoassay in the world. A novel antibody-duck IgY(ΔFc)•, has been employed in the Whole Blood CRP LIT assay. Duck anti-CRP IgY(ΔFc) is coupled to latex microparticles, which amplify the antigen-antibody reaction and thus greatly increase the detection sensitivity. Without the Fc domain, duck IgY(ΔFc) will not cross-react with the following factors which are common interferences for immunoassay: Complement, HAMA , Human IgG ,RF/ASO and Fc receptors etc. The sensitivity, precision, and accuracy of the assay can be highly improved by using duck IgY(ΔFc) as the material of immunodiagnostic reagents.
- The test is completed within 2-3 minutes by quantitative measurement of the degree of agglutination using a bench-top analyzer in small and medium-sized laboratories or doctors' offices as well as an automated chemistry analyzer (e.g. Hitachi series) in central laboratories. Besides, the use of whole blood for CRP measurement eliminates the need for sample centrifugation or transportation and thus is most suitable for rapid point-of-care testing.
- The technology platform of duck IgY(ΔFc) is solely owned by Good Biotech Corp. ; the manufacturing and the applications of duck IgY(ΔFc) antibody is patent-protected worldwide including all the major and dominant markets.
Major Specifications*
Reagent: |
Liquid stable, Ready-to-use reagent. |
Both single-reagent and two-reagent formats are avaliable |
|
Analyzer: |
General clinical chemistry analyzer (auto & bench-top) |
|
Specially for POCT devices |
Measurement: |
LIT (latex microparticle enhanced immonoturbidimetry) |
Sample type: |
Whole blood (capillary or venous whole blood), serum and plasma |
Sample volume: |
1μl |
Wave length: |
660nm, single wave length |
Assay time: |
96-168 seconds |
Assay range: |
Reliable assay range of 1.3-230 mg/L (whole blood) |
|
Reliable assay range of 0.6-200 mg/L (serum/plasma) |
Sensitivity: |
<1.0 mg/L (whole blood) |
<1.0 mg/L (serum/plasma) |
|
Detection limit: |
1.3 mg/L (whole blood) |
|
0.6 mg/L (serum/plasma) |
Antigen excess: |
In whole blood and serum/plasma, no hook effect up to 1000 mg/L |
Calibrator: |
Single set calibrator |
Correlation: |
Good correlation with other commercial latex kits. |
*Abovementioned results were obtained by Hitachi 917 (7170) analyzers.
Take a look at Whole Blood CRP LIT Assay-Your Strategic Partner for your POCT development
Click here for more information about Whole Blood CRP LIT Assay ( REF KT-0301-W).
To learn more about partnering opportunities with us, please contact partnership@good-biotech.com and share your ideas with us.